{"id":4417,"date":"2019-03-26T05:11:06","date_gmt":"2019-03-26T05:11:06","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4417"},"modified":"2019-11-12T15:29:11","modified_gmt":"2019-11-12T15:29:11","slug":"%e4%b8%80%e9%a1%b9%e5%85%b3%e4%ba%8eplx8394%e4%bd%9c%e4%b8%ba%e5%8d%95%e8%8d%af%e6%b2%bb%e7%96%97%e6%99%9a%e6%9c%9f%e4%b8%8d%e5%8f%af%e5%88%87%e9%99%a4%e5%ae%9e%e4%bd%93%e7%98%a4%e6%82%a3%e8%80%85","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/zh\/study_trials\/a-study-of-plx8394-as-a-single-agent-in-patients-with-advanced-unresectable-solid-tumors\/","title":{"rendered":"\u4e00\u9879\u5173\u4e8ePLX8394\u4f5c\u4e3a\u5355\u836f\u6cbb\u7597\u665a\u671f\u4e0d\u53ef\u5207\u9664\u5b9e\u4f53\u7624\u60a3\u8005\u7684\u7814\u7a76"},"content":{"rendered":"<p><strong>\u7814\u7a76\u76ee\u7684\uff1a<\/strong>&nbsp; \u8fd9\u9879\u4e34\u5e8a\u7814\u7a76\u65e8\u5728\u4e86\u89e3PLX8394\u53ef\u80fd\u5bf9\u643a\u5e26BRAF\u57fa\u56e0\u7a81\u53d8\u7684\u764c\u7ec6\u80de\u4ea7\u751f\u4f55\u79cd\u5f71\u54cd\u3002PLX8394\u7684\u8bbe\u8ba1\u76ee\u7684\u662f\u963b\u65adBRAF\u57fa\u56e0\u7684\u7a81\u53d8\u3002\u8fd9\u4e9b\u7a81\u53d8\u53ef\u80fd\u5bfc\u81f4\u764c\u75c7\u7684\u53d1\u751f\u548c\u764c\u7ec6\u80de\u7684\u589e\u6b96\u3002\u00a0 \u901a\u8fc7\u963b\u65ad\u8fd9\u4e9b\u7a81\u53d8\uff0c\u8be5\u836f\u7269\u53ef\u80fd\u6740\u6b7b\u643a\u5e26\u8be5\u7a81\u53d8\u7684\u764c\u7ec6\u80de\u548c\/\u6216\u963b\u6b62\u80bf\u7624\u751f\u957f\u3002.<\/p>\n<p><strong>\u8d5e\u52a9\u5546\uff1a<\/strong>&nbsp; Plexxikon<\/p>\n<p><strong>\u8bd5\u7528\u7248\u8054\u7cfb\u65b9\u5f0f\uff1a<\/strong>&nbsp; DivyaSakamuri\uff1b1-713-745-3296\uff1bdsakamuri@mdanderson.org \u6216 Filip Janku\uff1b713-563-1930\uff1bFJanku@mdanderson.org<\/p>\n<p><strong>\u8981\u6c42\u60a3\u8005\u53c2\u4e0e\uff1a<\/strong>&nbsp; 18\u5c81\u4ee5\u4e0a\u7684ECD\u60a3\u8005\u3002.<\/p>\n<p><strong>\u5df2\u77e5\u53c2\u4e0e\u8be5\u8bd5\u9a8c\u5e76\u63a5\u6536ECD\u60a3\u8005\u7684\u4e2d\u5fc3\uff1a<\/strong>&nbsp; MD\u5b89\u5fb7\u68ee\u764c\u75c7\u4e2d\u5fc3\uff0c\u5fb7\u514b\u8428\u65af\u5dde\u4f11\u65af\u987f\u5e02<\/p>\n<p><strong>ClinicalTrials.gov \u6807\u8bc6\u7b26\uff1a<\/strong>&nbsp; NCT02428712<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; The goal of this clinical research study is to learn how PLX8394 may affect cancer cells with mutations in the gene BRAF.&nbsp; PLX8394 is designed to block mutations [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4417","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials\/4417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/media?parent=4417"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials_cat?post=4417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}